Oculoplastic Surgery Market Size is Expected to Grow at 5.82% CAGR by 2026
Oculoplastic Surgery Market (By Procedure: Eyelid Surgery, Face Lift, Brow Lift & Forehead Lift, Pediatric Oculoplastic surgery, Others; By End user: Hospitals, ASCs and Clinics, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026
The global Oculoplastic Surgery Market size is anticipated to around USD 10,686.6 million by 2026, this market is anticipated to grow with 5.82% CAGR during the forecast time period.
Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1655
The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has the highest market share in the global oculoplastic surgery market in 2018. In North America, the United States dominated the regional oculoplastic surgery market, driven by the country's high number of procedures. Blepharoplasty-removal of excess tissue around the eyelids is one of the most common cosmetic procedures performed in the world, according to the American Society of Esthetic Plastic Surgeons. In 2018, 115,000 blepharoplasty procedures were performed in the United States.
The cost of plastic surgery conducted in developed countries varies considerably which is the main regional growth factor relative to developing countries. Due to a large number of beauty-conscious people and an increasing population, Japan is leading the APAC region. Asia Pacific is expected to register the fastest CAGR during the forecast period. Japan is leading the APAC region due to a large number of beauty-conscious people and rising aging populations. According to the International Society of Aesthetic Plastics, approximately 90% of all cosmetic surgery was performed on the face in 2017. Latin America is also expected to grow significantly in the forecast period due to an increase in the number of eye-related surgeries. According to the International Aesthetic Plastic Society, in 2017, Brazil recorded 159,720 eyelid procedures, which is more than the U.S. The North America, Europe, and Asia Pacific are expected to play significant role in the market during the forecast period to increase the revenue in the market.
View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/oculoplastic-surgery-market
On the basis of procedure, the eyelid surgery segment is expected to dominate the market and further expected to continue to dominate over the forecast period owing to increase research and development investment from the manufacturers. In 2015, over 1,264,702 eyelid surgeries were performed globally. The eyelid surgery segment, also referred to as eyelid surgery or blepharoplasty, removes excess skin from the upper eyelid and reduces bagginess from the lower eyelid. Browlift and forehead lift segment is expected to register the fastest growth during the forecast period owing to the high adoption of this surgery. The high growth rate of the segment is mainly attributed to the benefits of surgery, such as the reduction of eye bags and puffiness around the lower eyelids and the tightening of soft tissues on the forehead to provide a younger appearance.
In end user segment the ambulatory surgical centers segment is expected to have the highest CAGR over the forecast period in the market. The development of an outpatient surgery facility is helping to improve health care facilities as well as the medical equipment industry. Such surgical centers will deliver surgical procedures at a lower price than hospitals at 35% to 50%. The outpatient surgical centers accounted for the largest market share of more than 60% in 2018 and the segment is expected to dominate the market during the forecast period. The high proportion is mainly attributed to the increasing number of outpatient surgeries that do not require hospital stays.
The availability of an outpatient surgery center helps to transform healthcare facilities and the market for medical equipment. The hospitals segment is also expected to see significant growth over the forecast period. The key drivers are the growing prevalence of eye disorders, the increasing number of hospitals, the advancement of healthcare services and rising healthcare spending, and the growth of the segment in the private sector.
The key leading competitors in the global oculoplastic surgery market includes Integra Life Sciences, Sklar Surgical Instruments, TEKNO-MEDICAL Optik-Chirurge GmbH, Stanford Health Care, Zimmer Biomet holdings Inc., B. Braun Melsungen AG, Blink Medical Ltd, Shoyukai, Bolton Surgical Ltd, KarlzStorz, and BMT Medizintechnik GmbH.
Market Segmentation
Market By Procedure
- Eyelid Surgery
- Face Lift
- Brow Lift & Forehead Lift
- Pediatric Oculoplastic surgery
- Others
Market By End user
- Hospitals
- ASCs and Clinics
- Others
Market By Geography
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Key Questions Answered in the Report
The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-
- What is the overall structure of the market?
- What was the historical value and what is the forecasted value of the market?
- What are the key product level trends in the market?
- What are the market level trends in the market?
- Which of the market players are leading and what are their key differential strategies to retain their stronghold?
- Which are the most lucrative regions in the market space?
Some of the key observations regarding oculoplastic surgeryindustry include:
- In November 2017, companies such asIOPtima launched the iLid CO2 Laser-Assisted Blepharoplasty Kit to allow oculoplastic specialists to perform safe and effective eyelid surgery for patients. This strategy helped to expand the company's existing market product portfolio.
- In October 2017, Integra LifeSciences Holdings Corporation launch SurgiMend PRS Meshed Collagen Matrix for Breast Reconstruction in Europe.
- In January 2019, companies such as Integra LifeSciences Holdings Corporation launch Integra Titan Reverse Shoulder System-S. The new RSS-S baseplate was designed for immediate fixation with an independent central screw and the porous-coated central post allows the patient's bone to grow on the implant to further maximize the potential for long-term fixation.
Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1655
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Oculoplastic Surgery
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Oculoplastic Surgery Market By Procedure
1.2.2.1. Global Oculoplastic Surgery Market Revenue and Growth Rate Comparison By Procedure (2015-2026)
1.2.2.2. Global Oculoplastic Surgery Market Revenue Share By Procedure in 2018
1.2.2.3. Eyelid Surgery
1.2.2.4. Face Lift
1.2.2.5. Brow Lift & Forehead Lift
1.2.2.6. Pediatric Oculoplastic Surgery
1.2.2.7. Others
1.2.3. Oculoplastic Surgery Market By End user
1.2.3.1. Global Oculoplastic Surgery Market Revenue and Growth Rate Comparison By End user (2015-2026)
1.2.3.2. Global Oculoplastic Surgery Market Revenue Share By End user in 2018
1.2.3.3. Hospitals
1.2.3.4. ASCs and Clinics
1.2.3.5. Others
1.2.4. Oculoplastic Surgery Market By Geography
1.2.4.1. Global Oculoplastic Surgery Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Oculoplastic Surgery Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Oculoplastic Surgery Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Oculoplastic Surgery Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Oculoplastic Surgery Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Oculoplastic Surgery Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Oculoplastic Surgery Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Oculoplastic Surgery Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Oculoplastic Surgery Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Oculoplastic Surgery Major Manufacturers in 2018
CHAPTER 4. OCULOPLASTIC SURGERY MARKET BY PROCEDURE
4.1. Global Oculoplastic Surgery Revenue By Procedure
4.2. Eyelid Surgery
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Face Lift
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Brow Lift & Forehead Lift Pediatric Oculoplastic Surgery
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Pediatric Oculoplastic Surgery
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. OCULOPLASTIC SURGERY MARKET BY END USER
5.1. Global Oculoplastic Surgery Revenue By End user
5.2. Hospitals
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. ASCs and Clinics
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. NORTH AMERICA OCULOPLASTIC SURGERY MARKET BY COUNTRY
6.1. North America Oculoplastic Surgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Oculoplastic Surgery Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Oculoplastic Surgery Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
CHAPTER 7. EUROPE OCULOPLASTIC SURGERY MARKET BY COUNTRY
7.1. Europe Oculoplastic Surgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Oculoplastic Surgery Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
CHAPTER 8. ASIA-PACIFIC OCULOPLASTIC SURGERY MARKET BY COUNTRY
8.1. Asia-Pacific Oculoplastic Surgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Oculoplastic Surgery Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
CHAPTER 9. LATIN AMERICA OCULOPLASTIC SURGERY MARKET BY COUNTRY
9.1. Latin America Oculoplastic Surgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Oculoplastic Surgery Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
CHAPTER 10. MIDDLE EAST OCULOPLASTIC SURGERY MARKET BY COUNTRY
10.1. Middle East Oculoplastic Surgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Oculoplastic Surgery Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
CHAPTER 11. AFRICA OCULOPLASTIC SURGERY MARKET BY COUNTRY
11.1. Africa Oculoplastic Surgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Oculoplastic Surgery Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Procedure, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End user, 2015 - 2026 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Integra Life Sciences
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Sklar Surgical Instruments
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. TEKNO-MEDICAL Optik-Chirurge GmbH
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Stanford Health Care
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Zimmer Biomet holdings
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. B. Braun Melsungen AG
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Blink Medical Ltd
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Shoyukai
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Bolton Surgical Ltd
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Karlz Storz
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. BMT Medizintechnik GmbH
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Others
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1655
If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com | +1-407-915-4157 OR +1-408-900-9135
About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
Contact Us:
Phone: +14079154157 | +14089009135